Adfolic Tablets Usage And Safety
Dosage
Quatrefolic
Side Effects
Gastrointestinal disorders : Anorexia, nausea, abdominal distension and flatulence ; Immune system disorders : Allergic reactions, comprising erythema, rash, pruritus, urticaria, dyspnea, and anaphylactic reactions (including shock) .
Drug Interactions
Fosphenytoin : Folic acid along with fosphenytoin might decrease the effectiveness of fosphenytoin for preventing seizures ; Methotrexate : Folic acid along with methotrexate might decrease the effectiveness of methotrexate ; Phenobarbital : Folic acid can decrease the phenobarbital effect for preventing seizures ; Phenytoin : Folic acid along with phenytoin might decrease the effectiveness of phenytoin and increase the possibility of seizures ; Primidone : Folic acid along with primidone might decrease how well primidone works for preventing seizures ; Pyrimethamine : Folic acid might decrease the effectiveness of pyrimethamine for treating parasite infections ; Sulfasalazine : Sulfasalazine can reduce the absorption of folic acid.
Indication
? During pregnancy and lactation ? Pregnant women for prevention of neural tube defect in babies ? As a dietary supplement in adults and older people ? To prevent risk of spontaneous abortions ? In hyperhomocysteinemia ? Folate deficiency caused by some medicines (e.g. those used to treat epilepsy such as phenytoin, phenobarbital and primidone) ? Folate deficiency caused by long-term red blood cell damage or kidney dialysis ? In Depression, Cognitive impairment, Dementia and Alzheimer’s disease .
When not to Use
Long-term folate therapy is contraindicated in any patient with untreated cobalamin deficiency. This can be untreated pernicious anemia or other cause of cobalamin deficiency, including lifelong vegetarians. In elderly people, a cobalamin absorption test should be done before long-term folate therapy. Folate given to such patients for 3 months or longer has precipitated cobalamin neuropathy. No harm has occurred from short courses of folate ? Folic acid should never be given alone in the treatment of Addisonian, pernicious anemia and other vitamin B12 deficiency states because it may precipitate the onset of sub-acute combined degeneration of the spinal cord ? Folic acid should not be used in malignant disease unless megaloblastic anemia owing to folate deficiency is an important complication. ? Known hypersensitivity to the active ingredient.